Amgen, Inc. (NASDAQ:AMGN) fell 1.23% to $51.84. The stock has a
52-week range of $50.26-$61.26.
The stock
has average daily volume of 6.36 million shares. At current market price, the
market capitalization of the company stands at $48.33 billion.
Arena Pharmaceuticals, Inc.
(NASDAQ:ARNA) added 2.01%
to $1.53. The stock has a 52-week range of $1.26-$8.00.
Arena
Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on
discovering, developing and commercializing oral drugs that target G
protein-coupled receptors (GPCRs), in four major therapeutic areas:
cardiovascular, central nervous system, inflammatory and metabolic diseases.
Ariad Pharmaceuticals, Inc.
(NASDAQ:ARIA) lost 0.68%
to $5.88. ARIAD Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the discovery and development of drugs to provide therapeutic intervention in
treating human diseases at the cellular level.
The stock
has average daily volume of 2.19 million shares. At current market price, the
market capitalization of the company stands at $746.08 million.
Human Genome Sciences (NASDAQ:HGSI) jumped 12.25% to $28.83. Human Genome
Sciences is a commercially focused biopharmaceutical company.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today. Disclaimer: For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
